Premature Mortality from Cardiovascular Disease in the Americas - Will the Goal of a Decline of "25% by 2025" be Met?

Pedro Ordunez, Elisa Prieto-Lara, Vilma Pinheiro Gawryszewski, Anselm J M Hennis, Richard S Cooper, Pedro Ordunez, Elisa Prieto-Lara, Vilma Pinheiro Gawryszewski, Anselm J M Hennis, Richard S Cooper

Abstract

Background: Cardiovascular diseases (CVD) are the underlying cause 1.6 million deaths per year in the Americas, accounting for 30% of total mortality and 38% of by non-communicable deaths diseases (NCDs). A 25% reduction in premature mortality due four main NCDs was targeted by the 2011 High-level Meeting of the General Assembly on the Prevention and Control of NCDs. While overall CVD mortality fell in the Americas during the past decade, trends in premature CVD mortality during the same period have not been described, particularly in the countries of Latin America and the Caribbean.

Methods: This is a population-based trend-series study based on a total of 6,133,666 deaths to describe the trends and characteristics of premature mortality due to CVD and to estimates of the average annual percentage of change during the period 2000-2010 in the Americas.

Findings: Premature mortality due to CVD in the Americas fell by 21% in the period 2000-2010 with a -2.5% average annual rate of change in the last 5 year-a statistically significant reduction of mortality-. Mortality from ischemic diseases, declined by 25% - 24% among men and 26% among women. Cerebrovascular diseases declined by 27% -26% among men and 28% among women. Guyana, Trinidad and Tobago, the Dominican Republic, Bahamas, and Brazil had CVD premature mortality rates over 200 per 100,000 population, while the average for the Region was 132.7. US and Canada will meet the 25% reduction target before 2025. Mexico, Costa Rica, Venezuela, Dominican Republic, Panama, Guyana, and El Salvador did not significantly reduce premature mortality among men and Guyana, the Dominican Republic, and Panama did not achieve the required annual reduction in women.

Conclusions: Trends in premature mortality due to CVD observed in last decade in the Americas would indicate that if these trends continue, the Region as a whole and a majority of its countries will be able to reach the goal of a 25% relative reduction in premature mortality even before 2025.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

References

    1. Pan American Health Organization. Deaths due to Noncommunicable Diseases in countries of the Americas, Regional Mortality Database 2014. Accessed March 1, 2015. Available at: .
    1. United Nations General Assembly. Sixty-sixth Sessions. Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. A/66/L.1. New York: United Nations; 2011 Sep 16. Accessed March 1, 2015. Available at: .
    1. Bloom DE, Cafiero ET, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S, et al. (2011). The Global Economic Burden of Noncommunicable Diseases. Geneva: World Economic Forum.
    1. World Health Organization. Draft comprehensive global monitoring framework and targets for the prevention and control of noncommunicable diseases. 66th World Health Assembly; 15 March 2013; Geneva (Switzerland): WHO; 2013 (Document A66/8) Accessed March 1, 2015. Available at: .
    1. Lim SS, Gaziano TA, Gakidou E, Reddy KS, Farzadfar F, Lozano R, et al. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet. 2007; 15; 370: 2054–62.
    1. Pan American Health Organization/World Health Organization. Communicable Diseases and Health Analysis: Health Situation in the Americas: Basic Indicators 2014. Washington, D.C., USA, 2014. Accessed March 1, 2015. Available at: .
    1. de Souza MDFM, Gawryszewski VP, Orduñez P, Sanhueza A, Espinal MA: Cardiovascular disease mortality in the Americas: current trends and disparities. Heart 2012, 98(16):1207–1212. 10.1136/heartjnl-2012-301828
    1. Pan American Health Organization. Health in the Americas. Edition 2012. Washington, D.C., USA, 2012. Accessed March 01, 2015. Available at:
    1. Pan American Health Organization. Regional Health Observatory. Accessed March 1, 2015. Available at: .
    1. United Nations, Population Division. World Population Prospects: The 2012 Revision, New York; 2013. Accessed March 1, 2015. Available at:
    1. Ahmad OB, Boschi-Pinto C, Lopez AD, et al. Age standardization of rates: a new WHO standard–GPE Discussion Paper Series: No. 31. World Health Organization 2001. Accessed March 1, 2015. Available at: .
    1. Joinpoint Regression Program, Version 4.1.1.4—February 2015; Statistical Methodology and Applications Branch, Surveillance Research Program, National Cancer Institute; Accessed March 1, 2015. Available at: .
    1. Silvi J. On the estimation of mortality rates for countries of the Americas. Epidemiological Bulletin/ Pan American Health Organization. December 2003. 24 (4):1–5. Accessed March 1, 2015. Available at:
    1. Moreno LA. La década de América Latina y el Caribe, una oportunidad real Banco Interamericano de Desarrollo; 2011. Accessed March 1, 2015. Available at:
    1. Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L et al. on behalf of the American Heart Association Strategic Planning Task Force and Statistics Committee. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s Strategic Impact Goal through 2020 and beyond. Circulation. 2010; 121:586–613.
    1. Frieden TR, Berwick DM. The “Million Hearts” Initiative—Preventing Heart Attacks and Strokes. N Engl J Med 2011; 365:e27 10.1056/NEJMp1110421
    1. Huffman MD, Lloyd-Jones DM, Ning H, Labarthe DR, Guzman Castillo M, O’Flaherty M, et al. Quantifying Options for Reducing Coronary Heart Disease Mortality By 2020. Circulation. 2013;127:2477–2484
    1. Paim J, Travassos C, Almeida C, Bahia L, Macinko J. The Brazilian health system: history, advances, and challenges. Lancet 2011; 377: 1778–97 10.1016/S0140-6736(11)60054-8
    1. Baena CP, Chowdhury R, Schio NA, Sabbag AE Jr, Guarita-Souza LC, Olandoski M, et al. Ischaemic heart disease deaths in Brazil: current trends, regional disparities and future projections. Heart. 2013. 99(18):1359–64 10.1136/heartjnl-2013-303617
    1. Pan American Health Organization/World Health Organization. Department of Noncommunicable Diseases and Mental Health. Country Profile. Washington, D.C., USA, 2015. Accessed March 1, 2015. Available at: .
    1. Elder JP. Mexico and the USA: The world’s leaders in the obesity epidemic. Salud Pública de México 2013; 55: S355.
    1. Homedes N, Ugalde A. Twenty-Five Years of Convoluted Health Reforms in Mexico. PLoS Med. 2009; 6(8): e1000124 10.1371/journal.pmed.1000124
    1. McAlister FA, Wilkins K, Joffres M, Leenen FHH, Fodor G, Gee M MSc, et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades.CMAJ 2011; 183(9): 1007–1013 10.1503/cmaj.101767
    1. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al. Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000. N Engl J Med. 2007; 356:2388–2398.
    1. Rivera-Andrade A, Luna MA. Trends and Heterogeneity of Cardiovascular Disease and Risk Factors Across Latin America and Caribbean Countries. Prog Cardiovasc Dis. 2014. September 10. pii: S0033-0620(14)00136-4.
    1. Monteiro CA, Moura EC, Conde WL, Popkin BM. Socioeconomic status and obesity in adult populations of developing countries: a review. Bull World Health Organ. 2004; 82(12):940–946.
    1. Rivera JA, de Cossío TG, Pedraza LS, Aburto TC, Sánchez TG, Martorell R. Childhood and adolescent overweight and obesity in Latin America: a systematic review. Lancet Diabetes Endocrinol. 2014; 2(4):321–32. 10.1016/S2213-8587(13)70173-6
    1. Pan American Health Organization. Resolution CD53.R13. Plan of Action for the prevention of obesity in children and adolescents. Washington, DC: PAHO, 2014. Accessed March 1, 2015. Available at: .
    1. Organización Panamericana de la Salud. Informe sobre Control de Tabaco para la Región de las Américas Washington, DC: OPS; 2013. Accessed March 1, 2015. Available at: .
    1. Pan American Health Organization. Regional consultation: Priorities for cardiovascular health in the Americas Key messages for policymakers. Ordúñez-García P, Campillo-Artero C, eds. Washington, D.C.: PAHO; 2011. Accessed March 1, 2015. Available at: .
    1. Legetic B, Campbell N. Reducing salt intake in the Americas: Pan American Health Organization actions. J Health Commun. 2011; 2:37–48.
    1. Schargrodsky H, Hernández-Hernández R, Champagne BM, et al. CARMELA: assessment of cardiovascular risk in seven Latin American cities. Am J Med. 2008; 121(1):58–65. 10.1016/j.amjmed.2007.08.038
    1. Burroughs Peña MS, Abdala CVM, Silva LC, Ordúñez P. Usefulness for surveillance of hypertension prevalence studies in Latin America and the Caribbean: the past 10 years. Pan Am J Public Health. 2012; 32(1):15–21.
    1. Chow CK, Teo KK, Rangarajan S, et al., PURE (Prospective Urban Rural Epidemiology) Study investigators. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013; 310:959–968. 10.1001/jama.2013.184182
    1. Pan American Health Organization. Taller para acelerar la implementación del manejo del riesgo cardiovascular en los servicios de salud Pan American Health Organization; 2013. Accessed March 1, 2015. Available at: .
    1. Pan American Health Organization. Plan of Action for the Prevention and Control of Noncommunicable Diseases in the Americas 2013–2019. Washington, DC: PAHO, 2014. Accessed March 1, 2015. Available at: .
    1. Pan American Health Organization. Resolution CD53.R14. Strategy for Universal Access to Health and Universal Health Coverage. Washington, DC: PAHO, 2014. Accessed March 1, 2015. Available at: .

Source: PubMed

3
Abonner